GeneDx Holdings Corp. Gain (Loss) on Disposition of Assets
GeneDx Holdings Corp. (WGS) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-02-20
- GeneDx Holdings Corp. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for the quarter ending 2023-12-31 was -$1.28M.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was $0.00.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for fiscal 2023 was $1.68M.
- GeneDx Holdings Corp. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 10-K · filed 2025-02-20 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-07-30 | |||
| 2023-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$1.28M derived: sum of 2 quarters · filed 2025-02-20 | $1.68M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $2.95M 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $2.95M 10-Q · filed 2024-07-30 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $0.00 10-K · filed 2024-02-23 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |